Stock Price
244.80
Daily Change
-6.60 -2.63%
Monthly
-38.35%
Yearly
-61.70%
Q1 Forecast
285.47

Novo Nordisk reported DKK32.38B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Bausch Health Companies USD 719M 2M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Novo Nordisk DKK 5.18B 37.04B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025